Thirty Madison for Women: Who Should Avoid It and What to Know Before You Sign Up

What Thirty Madison Actually Is (and What It Is Not)

Thirty Madison is not a single telehealth clinic. It is a portfolio company that owns a collection of branded, condition-specific D2C platforms, each with its own intake flow, prescriber network, and formulary. The brands most relevant to women are Keeps for androgenetic alopecia, Cove for episodic and chronic migraine, Picnic for allergic rhinitis, and Evens for acid reflux and GI complaints.

The model is built on asynchronous care: you answer an intake questionnaire, a licensed prescriber reviews it, and a prescription is sent to a partner pharmacy if appropriate. In most cases you will never speak to that prescriber by video or phone unless you escalate. For straightforward, single-condition presentations this can be fast and affordable. For women with overlapping hormonal, reproductive, or autoimmune complexity, the model has real limitations.

How the Asynchronous Model Affects Women Differently

Women are more likely than men to present with conditions that interact with the menstrual cycle, hormonal contraception, thyroid status, and reproductive plans. Research published in JAMA Network Open has shown that women are consistently under-screened in digital health intake flows compared with their male counterparts, in part because questionnaires are designed around single-condition logic rather than the layered hormonal context most women carry.

A platform that asks only "do you have hair loss?" cannot adequately assess whether that hair loss is androgenetic, telogen effluvium triggered by postpartum hormone shifts, or the first sign of autoimmune thyroiditis. Getting the wrong answer here is not a minor inconvenience.

Is Thirty Madison Legit?

Yes, with significant caveats. Thirty Madison's prescribers are licensed in the states where they practice, and the company works with NABP-accredited partner pharmacies. The FDA has not issued any enforcement actions against Thirty Madison or its brands as of the date of this review. LegitScript, which certifies online pharmacies and telehealth operators, does not currently list Thirty Madison or Keeps as certified partners, which is a yellow flag worth noting when comparing platforms. The company is not BBB accredited, and the BBB profile for Thirty Madison Inc. Carries a pattern of complaints concentrated in billing errors, automatic subscription renewals, and prescription fulfillment delays.

Legit does not mean right for every patient. Those two things are different.

Specific Patient Profiles That Should Avoid Thirty Madison

This section is the core of what you came here to read. Each profile below represents a real category of women for whom the Thirty Madison model creates meaningful clinical risk or a high probability of receiving inadequate care.

Profile 1: Women Who Are Pregnant or Actively Trying to Conceive

This is the clearest contraindication. Keeps prescribes finasteride for hair loss. Finasteride is FDA Pregnancy Category X, meaning the known fetal risk outweighs any possible benefit. Even topical exposure to crushed or broken finasteride tablets poses a risk to a male fetus through skin absorption. Oral finasteride is absolutely contraindicated in pregnancy and in women who may become pregnant.

Cove prescribes topiramate for migraine prevention. ACOG's 2022 guidance on neurological disorders in pregnancy classifies topiramate as a teratogen with increased risk of oral clefts and small-for-gestational-age infants, and its use in pregnancy requires specialist-level risk-benefit counseling that an asynchronous intake platform cannot provide. Women of reproductive age prescribed topiramate through any platform should be counseled on reliable contraception, and that counseling is poorly suited to a text-based intake form.

If you are pregnant, planning pregnancy within the next 12 months, or not using consistent contraception while of reproductive age, the Thirty Madison model is not appropriate for conditions where these drugs sit in the formulary.

Profile 2: Perimenopausal and Postmenopausal Women with Hair Loss

Androgenetic alopecia in women is not the same disease as androgenetic alopecia in men, and it is not the same disease in a 28-year-old as in a 52-year-old. The American Academy of Dermatology notes that female pattern hair loss affects up to 40 percent of women by age 50, but the etiology in perimenopause involves declining estrogen and progesterone, rising androgen-to-estrogen ratios, and often co-occurring thyroid dysfunction, none of which a hair-loss-only platform is equipped to address.

Keeps was built primarily around male hair loss. Its formulary for women is limited, and its intake flow does not ask about menstrual cycle changes, vasomotor symptoms, FSH, LH, or thyroid function. A perimenopausal woman who signs up for Keeps and receives minoxidil alone is being managed for one variable in a multi-variable hormonal shift.

Minoxidil may still help, but prescribing it without addressing the hormonal substrate is incomplete care. If you are over 40 and experiencing new or worsening hair loss, start with a full thyroid panel, a reproductive hormone panel, and a ferritin level before accepting a D2C hair prescription.

Profile 3: Women with PCOS

PCOS affects 6 to 12 percent of women of reproductive age in the United States and is one of the most under-diagnosed, poorly managed conditions in women's health. Its presentations overlap with androgenetic alopecia (hair thinning, hair loss), hormonal acne, irregular cycles, insulin resistance, and fertility challenges.

A Thirty Madison hair-loss or acne platform cannot diagnose PCOS. It cannot order a pelvic ultrasound or measure androgen levels, LH-to-FSH ratios, or fasting insulin. A woman with undiagnosed PCOS who approaches Thirty Madison for hair loss or acne will receive symptomatic treatment without the underlying condition being identified. That delay has downstream consequences for metabolic health, fertility, and cardiovascular risk.

If you have irregular periods, unexplained weight gain concentrated around the abdomen, excess facial or body hair alongside scalp thinning, or difficulty conceiving, see a gynecologist or reproductive endocrinologist before engaging a D2C platform for any of those individual symptoms.

Profile 4: Women with Complex or Refractory Migraine

Cove is the Thirty Madison migraine brand, and for women with straightforward episodic migraine, it provides reasonable access to triptans and CGRP-targeted therapies at accessible price points. The problem is that migraine in women is not usually straightforward.

Menstrual migraine, which accounts for up to 70 percent of attacks in susceptible women, requires cycle-synchronized acute or preventive strategies that an asynchronous intake form is poorly positioned to design. Migraine that changes with hormonal contraceptive use, with perimenopause, or with pregnancy requires hormonal context that a headache platform is not designed to capture or manage. Women with migraine with aura face elevated stroke risk with combined hormonal contraceptives, a risk the American Heart Association has documented, and a Cove prescriber completing an asynchronous review may not have visibility into your full contraceptive history.

If your migraine pattern is tightly linked to your cycle, changes significantly with hormonal contraception, or has been refractory to two or more preventive agents, Cove is not the right level of care.

Profile 5: Women with Autoimmune Conditions or on Immunomodulating Medications

Picnic prescribes antihistamines, intranasal steroids, and allergen immunotherapy (subcutaneous and sublingual). Intranasal corticosteroids are generally safe but interact with systemic steroid regimens that women with lupus, rheumatoid arthritis, or inflammatory bowel disease often carry. Sublingual immunotherapy via an asynchronous platform poses a specific safety concern: the American Academy of Allergy, Asthma, and Immunology requires that the first dose of subcutaneous allergen immunotherapy be administered in a supervised clinical setting due to anaphylaxis risk.

Women on biologics, disease-modifying antirheumatic drugs, or systemic corticosteroids should not initiate allergen immunotherapy through a platform that cannot assess their full immunological picture.

Profile 6: Women Who Need Controlled Substances or Psychiatric Medications

The Thirty Madison formulary does not include controlled substances. If your migraine responds only to butalbital-containing compounds, if your anxiety requires benzodiazepines, or if your hair loss is complicated by a psychiatric condition requiring monitoring, this platform is the wrong tool.

Thirty Madison Complaints: What Women Report

Looking at verified complaint patterns from the BBB and app store reviews as of mid-2025, the most consistent themes from women users include:

• Billing after cancellation. Multiple complaints describe charges continuing after account closure, with customer service that is slow to issue refunds. For women on tight healthcare budgets, an unresolved $30 or $60 monthly charge is not trivial.
• Prescription fulfillment delays. Women report gaps between approval and pharmacy dispatch ranging from several days to several weeks, with limited visibility into where their prescription stands.
• Intake questionnaires that feel male-coded. Several Keeps users note that the intake questions did not ask about pregnancy status, breastfeeding, or menstrual cycle changes in a way that felt adequate for a female patient.
• Difficulty reaching a prescriber for follow-up. The asynchronous model means that if you have a question after your prescription is approved, routing to a human who can answer it is not always clear.

None of these complaints indicate fraud. They indicate a consumer-grade D2C operation that optimizes for volume and frictionless signup, not for the longitudinal care relationship that many women's health concerns require.

What Thirty Madison Does Well (To Be Fair)

A critical review should still be accurate. For the right patient profile, Thirty Madison brands offer real value.

Cove provides evidence-based triptan access and CGRP antagonists at prices below many in-office cash-pay options. For a woman in her 30s with clear episodic migraine, no hormonal complicating factors, and a prior diagnosis, Cove is a reasonable maintenance option. Picnic provides straightforward access to fluticasone propionate and loratadine at low cost for women with uncomplicated seasonal allergic rhinitis. Evens handles GERD with omeprazole and famotidine in a format that is convenient for women who have already had in-person GI workup and want a refill pathway.

The problem is not that these platforms exist. The problem is that the intake flow does not reliably screen for the patient profiles that should not be using them.

Pregnancy and Lactation: The Non-Negotiable Section

Because Thirty Madison brands prescribe drugs with serious reproductive risks, this section is required reading if you are pregnant, breastfeeding, or not using consistent contraception.

Finasteride (Keeps)

Finasteride is absolutely contraindicated in pregnancy. The FDA label states that women who are or may become pregnant must not handle crushed or broken finasteride tablets. There is no safe dose in pregnancy. Any woman of reproductive age prescribed oral finasteride through Keeps should be using reliable contraception, and that contraception conversation must happen with a prescriber who has time and context to have it, not an asynchronous intake form. Finasteride is not known to transfer into breast milk at clinically meaningful levels in lactating women, but data in humans is very limited and the drug should still be avoided during breastfeeding given the absence of safety data.

Topiramate (Cove)

The North American AED Pregnancy Registry has documented a 1.4 percent rate of oral clefts in infants exposed to topiramate in the first trimester, compared with a background rate of approximately 0.07 percent. Topiramate also passes into breast milk. The FDA requires a REMS program (the Topiramate REMS) for topiramate-containing products, and prescribers are expected to counsel women of childbearing potential about contraception. Whether that counseling is adequately delivered through an asynchronous Cove intake is a legitimate clinical question.

Triptans (Cove)

Triptan use in pregnancy carries a less severe but still uncertain risk profile. A 2010 analysis in BJOG found no statistically significant increase in major malformations with first-trimester triptan exposure, but data is limited. Sumatriptan has the most human pregnancy data. Women who become pregnant while using a Cove-prescribed triptan should discuss continuation with an OB or MFM physician.

Intranasal Corticosteroids (Picnic)

Fluticasone propionate and budesonide nasal sprays have reasonable safety data in pregnancy. ACOG considers intranasal corticosteroids appropriate first-line therapy for allergic rhinitis in pregnancy when symptoms impair quality of life. Systemic absorption from nasal spray is low.

The WomanRx "Right Platform, Wrong Patient" Checklist for Thirty Madison

Use this before you sign up. If you check any box in the "Do Not Proceed" column, seek care through a gynecologist, reproductive endocrinologist, or women's-health NP instead.

| Your situation | Thirty Madison appropriate? | |---|---| | Episodic migraine, prior OB/GYN clearance, not pregnant, on reliable contraception | Generally yes for Cove | | Menstrual migraine or migraine with aura on combined hormonal contraceptives | No. See a headache specialist | | Hair loss, under 40, no cycle irregularity, prior thyroid workup normal | Possibly yes for Keeps (minoxidil) | | Hair loss, perimenopausal or postmenopausal, no recent hormone panel | No. Get hormone and thyroid workup first | | Hair loss, irregular periods, possible PCOS | No. Needs full PCOS evaluation | | Pregnant or trying to conceive, any condition | No for finasteride or topiramate; discuss all others with OB | | Breastfeeding, any condition | Discuss all prescriptions with a lactation-informed clinician first | | Seasonal allergic rhinitis, no autoimmune disease, no systemic steroids | Generally yes for Picnic | | Allergic rhinitis plus lupus, RA, or biologic use | No. Needs specialist allergy review | | GERD, prior endoscopy, no alarm symptoms | Generally yes for Evens for refill management | | New-onset GI symptoms, not yet evaluated | No. Needs in-person GI evaluation first |

A Note on Evidence Gaps for Women

Women have historically been under-represented in the clinical trials that form the evidence base for androgenetic alopecia treatments, migraine prophylaxis, and allergy immunotherapy. A 2020 analysis in JAMA Internal Medicine found that women represented only 41 percent of participants in key clinical trials submitted to the FDA between 2000 and 2017 across all therapeutic areas. For hair loss specifically, most finasteride trials enrolled men only, and the evidence for finasteride in women comes from smaller, often open-label studies.

This matters for D2C platforms because the intake algorithms and dosing defaults often reflect male-derived data. When a Keeps prescriber approves 1 mg finasteride daily for a woman based on an asynchronous questionnaire, that dose is extrapolated from male trials. A 2023 paper in JAAD noted that the evidence base for oral minoxidil in women, while growing, remains substantially smaller than for men. Ask explicitly what data supports the dose you are being prescribed.

Who Thirty Madison Is Right For: The Honest Answer

The woman most likely to benefit from a Thirty Madison brand is 25 to 42 years old, has a clear single-condition diagnosis already confirmed by a prior in-person clinician, has no active pregnancy or fertility plans, has no autoimmune or complex hormonal comorbidities, and is looking for a convenient and lower-cost refill or maintenance pathway for a drug she has already tolerated.

That is a real population. It is not the majority of women seeking women's health care.

If your situation is more complex than a single, already-diagnosed, hormonally uncomplicated condition, the asynchronous D2C model is not built for you. Seek a clinician who can hold your full picture.